BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 20221430)

  • 21. Fragile X Syndrome Caused by Maternal Somatic Mosaicism of
    Gómez-Rodríguez MJ; Morales-Conejo M; Arteche-López A; Sánchez-Calvín MT; Quesada-Espinosa JF; Gómez-Manjón I; Palma-Milla C; Lezana-Rosales JM; Pérez de la Fuente R; Martin-Ramos ML; Fernández-Guijarro M; Moreno-García M; Alvarez-Mora MI
    Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reversion of FMR1 Methylation and Silencing by Editing the Triplet Repeats in Fragile X iPSC-Derived Neurons.
    Park CY; Halevy T; Lee DR; Sung JJ; Lee JS; Yanuka O; Benvenisty N; Kim DW
    Cell Rep; 2015 Oct; 13(2):234-41. PubMed ID: 26440889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fragile X founder effects and new mutations in Finland.
    Zhong N; Kajanoja E; Smits B; Pietrofesa J; Curley D; Wang D; Ju W; Nolin S; Dobkin C; Ryynänen M; Brown WT
    Am J Med Genet; 1996 Jul; 64(1):226-33. PubMed ID: 8826481
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Most Martin-Bell syndrome (FMR1-related disorder) Venezuelan patients did not show CGG expansion but instead display genetic heterogeneity.
    Vega Y; Arias S; Paradisi I
    J Hum Genet; 2017 Feb; 62(2):235-241. PubMed ID: 27708271
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intragenic loss of function mutations demonstrate the primary role of FMR1 in fragile X syndrome.
    Lugenbeel KA; Peier AM; Carson NL; Chudley AE; Nelson DL
    Nat Genet; 1995 Aug; 10(4):483-5. PubMed ID: 7670500
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the human fragile X mental retardation 1 polymerase chain reaction reagents to amplify the FMR1 gene: testing in a clinical diagnostic laboratory.
    Nahhas FA; Monroe TJ; Prior TW; Botma PI; Fang J; Snyder PJ; Talbott SL; Feldman GL
    Genet Test Mol Biomarkers; 2012 Mar; 16(3):187-92. PubMed ID: 21992462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcript levels of the intermediate size or grey zone fragile X mental retardation 1 alleles are raised, and correlate with the number of CGG repeats.
    Loesch DZ; Bui QM; Huggins RM; Mitchell RJ; Hagerman RJ; Tassone F
    J Med Genet; 2007 Mar; 44(3):200-4. PubMed ID: 16905681
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency of FMR1 gene mutation and CGG repeat polymorphism in intellectually disabled children in Pakistan.
    Fatima T; Zaidi SA; Sarfraz N; Perween S; Khurshid F; Imtiaz F
    Am J Med Genet A; 2014 May; 164A(5):1151-61. PubMed ID: 24478267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA Methylation, Mechanisms of
    Nobile V; Pucci C; Chiurazzi P; Neri G; Tabolacci E
    Biomolecules; 2021 Feb; 11(2):. PubMed ID: 33669384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetics of fragile X syndrome and fragile X-related disorders.
    Kraan CM; Godler DE; Amor DJ
    Dev Med Child Neurol; 2019 Feb; 61(2):121-127. PubMed ID: 30084485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contraction of fully expanded FMR1 alleles to the normal range: predisposing haplotype or rare events?
    Maia N; Loureiro JR; Oliveira B; Marques I; Santos R; Jorge P; Martins S
    J Hum Genet; 2017 Feb; 62(2):269-275. PubMed ID: 27784894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for
    Hnoonual A; Jankittunpaiboon C; Limprasert P
    Biomed Res Int; 2021; 2021():4359308. PubMed ID: 34926684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary evidence of an effect of cerebellar volume on postural sway in FMR1 premutation males.
    Birch RC; Hocking DR; Cornish KM; Menant JC; Georgiou-Karistianis N; Godler DE; Wen W; Hackett A; Rogers C; Trollor JN
    Genes Brain Behav; 2015 Mar; 14(3):251-9. PubMed ID: 25689687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel fragile X syndrome mutation reveals a conserved role for the carboxy-terminus in FMRP localization and function.
    Okray Z; de Esch CE; Van Esch H; Devriendt K; Claeys A; Yan J; Verbeeck J; Froyen G; Willemsen R; de Vrij FM; Hassan BA
    EMBO Mol Med; 2015 Apr; 7(4):423-37. PubMed ID: 25693964
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An origin of DNA replication in the promoter region of the human fragile X mental retardation (FMR1) gene.
    Gray SJ; Gerhardt J; Doerfler W; Small LE; Fanning E
    Mol Cell Biol; 2007 Jan; 27(2):426-37. PubMed ID: 17101793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expansion mutation frequency and CGG/GCC repeat polymorphism in FMR1 and FMR2 genes in an Indian population.
    Sharma D; Gupta M; Thelma BK
    Genet Epidemiol; 2001 Jan; 20(1):129-144. PubMed ID: 11119302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Loss of the KH1 domain of FMR1 in humans due to a synonymous variant causes global developmental retardation.
    Carion N; Briand A; Cuisset L; Pacot L; Afenjar A; Bienvenu T
    Gene; 2020 Aug; 753():144793. PubMed ID: 32446918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Chromatin changes caused by CGG repeat expansion in fmr1 gene].
    Yudkin DV; Lemskaya NA; Grischenko IV; Dolskiy AA
    Mol Biol (Mosk); 2015; 49(2):205-11. PubMed ID: 26065250
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of a screening tool for the rapid and reliable detection of CGG trinucleotide repeat expansions in FMR1.
    Basehore MJ; Marlowe NM; Jones JR; Behlendorf DE; Laver TA; Friez MJ
    Genet Test Mol Biomarkers; 2012 Jun; 16(6):465-70. PubMed ID: 22224633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deletion in the FMR1 gene in a fragile-X male.
    Mannermaa A; Pulkkinen L; Kajanoja E; Ryynänen M; Saarikoski S
    Am J Med Genet; 1996 Aug; 64(2):293-5. PubMed ID: 8844068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.